(NASDAQ: BLLN) Billiontoone's forecast annual revenue growth rate of 22.62% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.34%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.49%.
Billiontoone's revenue in 2026 is $397,412,000.On average, 10 Wall Street analysts forecast BLLN's revenue for 2026 to be $21,968,869,282, with the lowest BLLN revenue forecast at $20,809,483,758, and the highest BLLN revenue forecast at $22,771,520,798. On average, 10 Wall Street analysts forecast BLLN's revenue for 2027 to be $27,825,252,568, with the lowest BLLN revenue forecast at $25,711,273,265, and the highest BLLN revenue forecast at $29,480,101,991.
In 2028, BLLN is forecast to generate $34,770,712,691 in revenue, with the lowest revenue forecast at $29,975,094,019 and the highest revenue forecast at $41,123,503,617.